434 related articles for article (PubMed ID: 25459055)
1. Magnetic bead droplet immunoassay of oligomer amyloid β for the diagnosis of Alzheimer's disease using micro-pillars to enhance the stability of the oil-water interface.
Kim JA; Kim M; Kang SM; Lim KT; Kim TS; Kang JY
Biosens Bioelectron; 2015 May; 67():724-32. PubMed ID: 25459055
[TBL] [Abstract][Full Text] [Related]
2. Droplet-based magnetic bead immunoassay using microchannel-connected multiwell plates (μCHAMPs) for the detection of amyloid beta oligomers.
Park MC; Kim M; Lim GT; Kang SM; An SS; Kim TS; Kang JY
Lab Chip; 2016 Jun; 16(12):2245-53. PubMed ID: 27185215
[TBL] [Abstract][Full Text] [Related]
3. Magneto-immunocapture with on-bead fluorescent labeling of amyloid-β peptides: towards a microfluidized-bed-based operation.
Mai TD; Pereiro I; Hiraoui M; Viovy JL; Descroix S; Taverna M; Smadja C
Analyst; 2015 Sep; 140(17):5891-900. PubMed ID: 26206107
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
5. A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid.
Savage MJ; Kalinina J; Wolfe A; Tugusheva K; Korn R; Cash-Mason T; Maxwell JW; Hatcher NG; Haugabook SJ; Wu G; Howell BJ; Renger JJ; Shughrue PJ; McCampbell A
J Neurosci; 2014 Feb; 34(8):2884-97. PubMed ID: 24553930
[TBL] [Abstract][Full Text] [Related]
6. A polymer lab-on-a-chip for magnetic immunoassay with on-chip sampling and detection capabilities.
Do J; Ahn CH
Lab Chip; 2008 Apr; 8(4):542-9. PubMed ID: 18369508
[TBL] [Abstract][Full Text] [Related]
7. Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.
Hülsemann M; Zafiu C; Kühbach K; Lühmann N; Herrmann Y; Peters L; Linnartz C; Willbold J; Kravchenko K; Kulawik A; Willbold S; Bannach O; Willbold D
J Alzheimers Dis; 2016 Jul; 54(1):79-88. PubMed ID: 27472876
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-sensitivity immunoassay for amyloid-beta 1-42 using a silicon microarray platform.
Gagni P; Sola L; Cretich M; Chiari M
Biosens Bioelectron; 2013 Sep; 47():490-5. PubMed ID: 23624018
[TBL] [Abstract][Full Text] [Related]
9. Selective amyloid β oligomer assay based on abasic site-containing molecular beacon and enzyme-free amplification.
Zhu L; Zhang J; Wang F; Wang Y; Lu L; Feng C; Xu Z; Zhang W
Biosens Bioelectron; 2016 Apr; 78():206-212. PubMed ID: 26613510
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive/selective 3D nanostructured immunoparticle-based interface on a multichannel sensor array for detecting amyloid-beta in Alzheimer's disease.
Liu TC; Lee YC; Ko CY; Liu RS; Ke CC; Lo YC; Hong PS; Chu CY; Chang CW; Wu PW; Chen YY; Chen SY
Theranostics; 2018; 8(15):4210-4225. PubMed ID: 30128048
[TBL] [Abstract][Full Text] [Related]
11. Integrated electrokinetic magnetic bead-based electrochemical immunoassay on microfluidic chips for reliable control of permitted levels of zearalenone in infant foods.
Hervás M; López MA; Escarpa A
Analyst; 2011 May; 136(10):2131-8. PubMed ID: 21394379
[TBL] [Abstract][Full Text] [Related]
12. Magnetic immunoassay platform based on the planar frequency mixing magnetic technique.
Kim CB; Lim EG; Shin SW; Krause HJ; Hong H
Biosens Bioelectron; 2016 Sep; 83():293-9. PubMed ID: 27135936
[TBL] [Abstract][Full Text] [Related]
13. Nano-biosensors to detect beta-amyloid for Alzheimer's disease management.
Kaushik A; Jayant RD; Tiwari S; Vashist A; Nair M
Biosens Bioelectron; 2016 Jun; 80():273-287. PubMed ID: 26851586
[TBL] [Abstract][Full Text] [Related]
14. A low cost and high throughput magnetic bead-based immuno-agglutination assay in confined droplets.
Teste B; Ali-Cherif A; Viovy JL; Malaquin L
Lab Chip; 2013 Jun; 13(12):2344-9. PubMed ID: 23640128
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-amyloid-beta antibodies and Alzheimer's disease in elderly Korean patients.
Song MS; Mook-Jung I; Lee HJ; Min JY; Park MH
J Int Med Res; 2007; 35(3):301-6. PubMed ID: 17593857
[TBL] [Abstract][Full Text] [Related]
16. Moving the solid phase: a platform technology for cartridge based sandwich immunoassays.
Gottheil R; Baur N; Becker H; Link G; Maier D; Schneiderhan-Marra N; Stelzle M
Biomed Microdevices; 2014 Feb; 16(1):163-72. PubMed ID: 24091714
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of an antibody-aptamer sandwich assay for electrochemical evaluation of levels of β-amyloid oligomers.
Zhou Y; Zhang H; Liu L; Li C; Chang Z; Zhu X; Ye B; Xu M
Sci Rep; 2016 Oct; 6():35186. PubMed ID: 27725775
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
19. Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology.
Szekeres PG; Leong K; Day TA; Kingston AE; Karran EH
J Biomol Screen; 2008 Feb; 13(2):101-11. PubMed ID: 18216395
[TBL] [Abstract][Full Text] [Related]
20. Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease.
Van Thanh Nguyen N; Taverna M; Smadja C; Mai TD
Chem Rec; 2021 Jan; 21(1):149-161. PubMed ID: 33112020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
